Skip to main content
OpenTrials

Clinical trial condition

Purine-Pyrimidine Metabolism, Inborn Errors

Explore clinical trials studying Purine-Pyrimidine Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

266 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Purine-Pyrimidine Metabolism, Inborn Errors trial results

Recruiting

The Orienting Study

NCT07504146

Conditions
Arthritis, CPPD - Calcium Pyrophosphate Deposition Disease, Chondrocalcinosis, +12 more
Locations
  • IRCCS Ospedale Galeazzi-Sant'Ambrogio Milan, Milano, Italy
View Trial Details
Recruiting

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

NCT05658575

Conditions
Acute Gout Flare, Arthralgia, Arthritis, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Arthritis & Rheumatology Associates - Glendale Glendale, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates (AARA), P.C. - Mesa Mesa, Arizona, United States
  • American Institute of Research Los Angeles, California, United States
View all 40 locations
View Trial Details
Recruiting

Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer

NCT06245356

Conditions
Colonic Diseases, Colorectal Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • CHU Amiens Amiens, France
  • Institut de Cancérologie de l'Ouest Angers, France
  • Institut du Cancer d'Avignon Avignon, France
  • CHU Jean Minjoz Besançon, France
View all 21 locations
View Trial Details
Recruiting

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

NCT07145229

Conditions
Acute Gout Flare, Acute Gouty Arthritis, Arthritis, +13 more
Locations
  • Onyx Clinical Research Peoria, Arizona, United States
  • Exinia Research La Mesa, California, United States
  • Evergreen Clinical Trial Norcross, Georgia, United States
  • Bioluminux Clinical Research Naperville, Illinois, United States
View all 38 locations
View Trial Details

Related conditions